Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia  

Oleh:

Fortier, Emmanuel ; Alavi, Maryam ; Bruneau, Julie ; Micallef, Michelle ; Perram, Jacinta ; Sockalingam, Sanjeev ; Dunlop, Adrian J. ; Balcomb, Annie C. ; Day, Carolyn A. ; Treloar, Carla ; Bath, Nicky ; Haber, Paul S. ; Dore, Gregory J. ; Grebely, Jason

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Journal of Addiction Medicine vol. 11 no. 01 (Jan. 2017), page 10-18.
Topik: Anxiety; Depression; Hepatitis C Virus; People Who Inject Drugs; Stress
Fulltext: J06 v11 n1 p10 kelik2017.pdf (120.91KB)

Ketersediaan

Perpustakaan FK Nomor Panggil: J06.K Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Objective: The aims of this study were to assess symptoms of depression, anxiety, and stress and associated sociodemographic factors among people living with chronic hepatitis C virus (HCV) infection with a history of injecting drug use and to assess the association between symptoms of depression, anxiety, or stress and HCV treatment intent, specialist assessment, or treatment uptake. Methods: The Enhancing Treatment for Hepatitis C in Opioid Substitution Settings was an observational cohort study evaluating the provision of HCV assessment and treatment among people with chronic HCV and a history of injecting drug use, recruited from 9 community health centers and opioid substitution therapy (OST) clinics (New South Wales, Australia). Symptoms were assessed using the Depression Anxiety Stress Scales (DASS-21). Analyses were performed using logistic regression. Results: Among 415 participants (mean age 41 years, 71% male), 47%, 52%, and 36% demonstrated moderate to extremely severe symptoms of depression, anxiety, and stress, respectively. In adjusted analyses, depression symptoms were associated with recent injecting drug use [adjusted odds ratio (aOR) 1.63, 95% confidence interval (CI) 1.07–2.49), whereas stress symptoms were associated with unemployment (aOR 2.99, 95% CI 1.09–8.15) and not living with a spouse or other relatives/friends (aOR 1.55, 95% CI 1.01–2.39). Symptoms of depression, anxiety, or stress or having a history of treated mental illness were not independently associated with HCV treatment intent, specialist assessment, or treatment uptake. Conclusions: Findings suggest a need for improved interventions and care regarding mental health among people living with chronic HCV with a history of injecting drug use, but suggest that symptoms of depression, anxiety, and stress should not be immediate contraindications to HCV assessment and treatment.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali